Abortion Providers Gear Up for Judge’s Ruling Over Pill Approval
This article is for subscribers only.
Health providers are bracing for massive disruptions as they await a federal judge’s decision on whether to halt national access to an abortion pill approved decades ago by the Food and Drug Administration.
Trump-appointed Judge Matthew Kacsmaryk is expected to rule soon on the Alliance Defending Freedom’s request for a preliminary injunction stopping the sale and distribution of mifepristone, a drug used as part of a regimen to end a pregnancy within the first 10 weeks. Such a ban, advocates say, would push health groups to guide patients and doctors to alternative ways to access reproductive services.